Black Diamond Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Black Diamond Therapeutics, Inc.‘s stocks are currently a part of 26 hedge funds’ portfolios, which represents 8.77% of the total amount of its stocks outstanding. This makes up a total of 3.18M shares of Black Diamond Therapeutics, Inc.. Compared to the previous quarter, the number fell by -84.87% or -17.86M shares fewer. As for the holding position changes, 15.38% (4) of current hedge fund investors increased the number of shares held, 34.62% (9) of current holders sold a part of the shares held, and 19.23% (5) closed the holdings completely.
Hedge funds holding Black Diamond Therapeutics (Q1 2016 – Q1 2023)
| Q1 2016 | 1 |
|---|---|
| Q2 2016 | 0 |
| Q3 2016 | 0 |
| Q4 2016 | 0 |
| Q1 2020 | 65 |
| Q2 2020 | 80 |
| Q3 2020 | 88 |
| Q4 2020 | 109 |
| Q1 2021 | 110 |
| Q2 2021 | 97 |
| Q3 2021 | 93 |
| Q4 2021 | 85 |
| Q1 2022 | 70 |
| Q2 2022 | 56 |
| Q3 2022 | 57 |
| Q4 2022 | 55 |
| Q1 2023 | 26 |
Hedge funds changes in Black Diamond Therapeutics positions (Q1 2016 – Q1 2023)
| Q1 2016 | 0 | 1 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2016 | 0 | 0 | 0 | 1 | -1 |
| Q3 2016 | 0 | 0 | 0 | 0 | 0 |
| Q4 2016 | 0 | 0 | 0 | 0 | 0 |
| Q1 2020 | 65 | 0 | 0 | 0 | 0 |
| Q2 2020 | 20 | 30 | 12 | 4 | 14 |
| Q3 2020 | 19 | 38 | 18 | 11 | 2 |
| Q4 2020 | 33 | 43 | 11 | 12 | 10 |
| Q1 2021 | 21 | 36 | 31 | 20 | 2 |
| Q2 2021 | 23 | 41 | 12 | 36 | -15 |
| Q3 2021 | 12 | 23 | 35 | 15 | 8 |
| Q4 2021 | 18 | 20 | 28 | 26 | -7 |
| Q1 2022 | 10 | 21 | 24 | 25 | -10 |
| Q2 2022 | 9 | 10 | 24 | 20 | -7 |
| Q3 2022 | 9 | 10 | 23 | 8 | 7 |
| Q4 2022 | 13 | 9 | 24 | 16 | -7 |
| Q1 2023 | 0 | 4 | 9 | 5 | 8 |
Hedge funds changes in Black Diamond Therapeutics stock options (Q1 2016 – Q1 2023)
| Q1 2016 | 5,000 | 0 |
|---|---|---|
| Q2 2016 | 3,000 | 0 |
| Q3 2016 | 2,000 | 0 |
| Q4 2016 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 1,198,000 | 1,321,000 |
| Q2 2021 | 946,000 | 1,416,000 |
| Q3 2021 | 433,000 | 705,000 |
| Q4 2021 | 87,000 | 260,000 |
| Q1 2022 | 3,000 | 192,000 |
| Q2 2022 | 947,000 | 925,000 |
| Q3 2022 | 844,000 | 807,000 |
| Q4 2022 | 50,000 | 76,680 |
| Q1 2023 | 1,000 | 0 |